Abstract：Objective To analyze the clinical significance of treatment of patients with chronic obstructive pulmonary disease (COPD) with seretide combined with spiriva.Methods Sixty patients diagnosed with chronic obstructive pulmonary disease (COPD) and treated between 2013 and 2015 were selected as subjects. Thirty of them received conventional treatment and served as control group while the rest took seretide and spiriva and served as observation group. The clinical efficacy of different intervention programs was compared.Results After treatment, the total effective rate was 83.3% in control group, butwas 96.7% in observation group,and the difference was statistically significant (P<0.05). FEV1 and FEV1/FVC of observation group were greater than those of control group, and the difference was statistically significant (P<0.05). After 5 months of treatment,the therapeutic effect was better in observation group than in control group in terms of the 6 min walking distance and quality of life (P<0.05), and the difference was statistically significant.Conclusions In patients with chronic obstructive pulmonary disease (COPD), treatment with seretide combined with spiriva can significantly improve clinical efficacy and recovery of physical functions of patients.
王华琳,杨 敏,侯英宇,王 宇. 沙美特罗联合噻托溴铵治疗慢性阻塞性肺疾病的效果[J]. 武警医学, 2017, 28(1): 30-31.
WANG Hualin, YANG Min, HOU Yinyu, and WANG Yu. Clinical efficacy of seretide combined with spiriva in treatment of patients with chronic obstructive pulmonary disease. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(1): 30-31.
2017, Vol. 28 
